European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287
European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287
1415
Flavell, David J.
3a0f7124-7d44-42bc-b6f6-6fb12552fbd6
Flavell, Sopsamorn U.
fa2b4670-1836-42e2-b68a-5d646899d711
Sullivan, Richard
0bd7e653-23cf-4d08-89aa-1b8bc98f79a6
2003
Flavell, David J.
3a0f7124-7d44-42bc-b6f6-6fb12552fbd6
Flavell, Sopsamorn U.
fa2b4670-1836-42e2-b68a-5d646899d711
Sullivan, Richard
0bd7e653-23cf-4d08-89aa-1b8bc98f79a6
Flavell, David J., Flavell, Sopsamorn U. and Sullivan, Richard
(2003)
European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287.
The Lancet, 362 (9393), .
(doi:10.1016/S0140-6736(03)14646-6).
This record has no associated files available for download.
More information
Published date: 2003
Organisations:
Cancer Sciences
Identifiers
Local EPrints ID: 26308
URI: http://eprints.soton.ac.uk/id/eprint/26308
PURE UUID: 1474e9aa-d355-46f8-93e0-9cc14c1cf04b
Catalogue record
Date deposited: 24 Apr 2006
Last modified: 15 Aug 2024 17:11
Export record
Altmetrics
Contributors
Author:
David J. Flavell
Author:
Sopsamorn U. Flavell
Author:
Richard Sullivan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics